# Neo-adjuvant Immunotherapy in Patients With Localized Melanoma

> clinical trial · VERIFIED · 2026-07-21

Status: RECRUITING · Sponsor: UNICANCER · Condition: Cutaneous Melanoma, Stage III

- Company: UNICANCER
- Sector: Cutaneous Melanoma, Stage III
- Primary source: https://clinicaltrials.gov/study/NCT07230613

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.